Market Research Logo

Global Gout Therapeutics Market 2016-2020

Global Gout Therapeutics Market 2016-2020

About Gout Therapeutics

Gout is one type of arthritis, which is caused by the high levels of uric acid in the blood. The main symptoms of gout are sudden attack of burning pain, swelling in a joint, and stiffness, usually in toe. If it is not treated, over time, it can harm tendons, joints, and other tissues. NSAIDs and urate-lowering agents are preferred treatment options for gout.

Technavio’s analysts forecast the global gout therapeutics market to grow at a CAGR of 17.16% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global gout therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of gout and the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs.The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Gout Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • AstraZeneca
  • Horizon Pharma
  • Takeda Pharmaceuticals
Other prominent vendors
  • Ablynx
  • Alder Biopharmaceuticals
  • Antares Pharma
  • Astellas Pharma
  • Boehringer Ingelheim
  • Can-Fite BioPharma
  • Celgene
  • Celltrion
  • ChemoCentryx
  • CymaBay Therapeutics
  • Eisai
  • Eli Lilly
  • Gilead Sciences
  • GlaxoSmithKline
  • Incyte
  • Ironwood Pharmaceuticals
  • JW Pharmaceutical
  • KaloBios Pharmaceuticals
  • Lexicon Pharmaceuticals
  • LG Life Sciences
  • Merck
  • Morphotek
  • Novartis
  • Novo Nordisk
  • Regeneron Pharmaceuticals
  • Sandoz
  • Sanofi
  • Santarus
  • Selecta Biosciences
  • Teijin Pharma
  • UCB
  • Vertex Pharmaceuticals.
Market driver
  • Introduction of novel urate-lowering agents
  • For a full, detailed list, view our report
Market challenge
  • Low physician and patient awareness
  • For a full, detailed list, view our report
Market trend
  • Focus on regenerative medicines
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Gout Therapeutics Market 2016-2020

Technavio recognizes the following companies as the key players in the global gout therapeutics market: AstraZeneca, Horizon Pharma, and Takeda Pharmaceuticals.

Other Prominent Vendors in the market are: Ablynx, Alder Biopharmaceuticals, Antares Pharma, Astellas Pharma, Boehringer Ingelheim, Can-Fite BioPharma, Celgene, Celltrion, ChemoCentryx, CymaBay Therapeutics, Eisai, Eli Lilly, Gilead Sciences, GlaxoSmithKline, Incyte, Ironwood Pharmaceuticals, JW Pharmaceutical, KaloBios Pharmaceuticals, Lexicon Pharmaceuticals, LG Life Sciences, Merck, Morphotek, Novartis, Novo Nordisk, Regeneron Pharmaceuticals, Sandoz, Sanofi, Santarus, Selecta Biosciences, Teijin Pharma, UCB, and Vertex Pharmaceuticals.

Commenting on the report, an analyst from Technavio’s team said: “The use of regenerative medicine is an emerging treatment option for the treatment of gout. These regenerative medicines help in the healing process by replacement or regeneration of the human cells, tissues or organs, and thus help in establishing the normal function. The various regenerative techniques include cell therapy, growth factor therapy, and others.”

According to the report, introduction of novel urate-lowering agents will drive growth in this market.Urate-lowering agents are increasingly becoming the preferred choice of treatment for gout, which will be used as add-on therapy to the existing standard of care and target the gout patients who failed the previous treatment.

Further, the report states that the use of CAM for the treatment of gout is one challenge, which is expected to be increase during the forecast period. The National Arthritis Foundation reveals that more than one-third of gout arthritis patients in the US prefer CAM therapies.

Companies Mentioned

AstraZeneca, Horizon Pharma, Takeda Pharmaceuticals, Ablynx, Alder Biopharmaceuticals, Antares Pharma, Astellas Pharma, Boehringer Ingelheim, Can-Fite BioPharma, Celgene, Celltrion, ChemoCentryx, CymaBay Therapeutics, Eisai, Eli Lilly, Gilead Sciences, GlaxoSmithKline, Incyte, Ironwood Pharmaceuticals, JW Pharmaceutical, KaloBios Pharmaceuticals, Lexicon Pharmaceuticals, LG Life Sciences, Merck, Morphotek, Novartis, Novo Nordisk, Regeneron Pharmaceuticals, Sandoz, Sanofi, Santarus, Selecta Biosciences, Teijin Pharma, UCB, Vertex Pharmaceuticals.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
      • Table Global gout therapeutics market overview
  • Gout: Disease overview
    • Table Stages of gout
    • Table Mechanism of gout
    • Table Gout: overview
    • Table Treatment algorithm for gout
  • Pipeline portfolio
    • Table Pipeline analysis of major companies for global gout therapeutics market
    • Table Share of pipeline molecules in global gout therapeutics market
    • Table Few pipeline candidates under development in global gout therapeutics market:
  • Market landscape
    • Market overview
      • Table Market snapshot: Global gout therapeutics market
      • Table Global statistics for gout in 2015
      • Table Correlation between serum uric acid concentration and cigarette smoking status
      • Table Factors influencing the global gout therapeutics market 2015
      • Table Global gout therapeutics market snapshot: Developed and emerging markets 2015
      • Table Global gout therapeutics market 2015-2020 ($ billions)
      • Table Opportunities in gout arthritis industry today
      • Table Impact of drivers and challenges of global gout therapeutics market
    • Five forces analysis
      • Table Five forces analysis
  • Key buying criteria
    • Table Key buying criteria for gout therapeutics market
    • Table Key buying criteria for global gout therapeutics market 2015
    • Table Impact of key customer segments on global gout therapeutics market 2015
  • Market segmentation by drug class
    • Table Market segmentation by drug class: Global gout therapeutics market
    • NSAIDs
      • Table Common NSAIDs used for treatment of gout
    • Corticosteroids
    • Colchicine
    • Urate-lowering agents
      • Table Market segmentation by drug class: Present and future scenarios
  • Market segmentation by type of disease
    • Table Global gout therapeutics market: Segmentation by type 2015-2020
    • Table Global gout therapeutics market segmentation: Growth cycle analysis
    • Table Snapshot of global gout therapeutics market by segmentation
  • Geographical segmentation
    • Table Snapshot of global gout therapeutics market by geography
    • Table Global gout therapeutics market revenue by geography 2015-2020 ($ millions)
    • Table Percentage share of global gout therapeutics market by geography 2015
    • Table Percentage share of global gout therapeutics market by geography 2020
    • Table Global gout therapeutics market: Country analysis based on revenue and growth rate
    • Gout therapeutics market in Americas
      • Table Gout therapeutics market in Americas 2015-2020 ($ millions)
    • Gout therapeutics market in EMEA
      • Table Gout therapeutics market in EMEA 2015-2020 ($ millions)
    • Gout therapeutics market in APAC
      • Market overview
        • Table Opportunity of RDEA3170 in APAC
        • Table Gout therapeutics market in APAC 2015-2020 ($ millions)
  • Market drivers
    • Introduction of novel urate-lowering agents
      • Table Phase III clinical study data and future opportunities for urate-lowering agent - Zurampic (lesinurad)
    • Technological advancements in medical imaging
    • Popularity of off-label and OTC drugs
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Low physician and patient awareness
    • Heavy dependency on generic drugs
    • Use of CAM for treatment of gout
      • Table Common CAM therapies used for gout treatment
      • Table Usage of CAM therapies in US adults 2015
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Table Impact of trends on global gout therapeutics market
    • Focus on regenerative medicines
    • High growth potential of biologics
    • Preference for combination therapies
  • Vendor landscape
    • Competitive scenario
      • Table Ranking of major vendors for global gout therapeutics market
      • Table Geographical presence of key vendors
      • Table Company portfolio analysis in global gout therapeutics market 2016-2020
    • Other prominent vendors
  • Key vendor analysis
    • AstraZeneca
      • Table AstraZeneca: Key highlights
      • Table AstraZeneca: Strength assessment
      • Table AstraZeneca: Strategy assessment
      • Table AstraZeneca: Opportunity assessment
    • Horizon Pharma
      • Table Horizon Pharma: Key highlights
      • Table Horizon Pharma: Strength assessment
      • Table Horizon Pharma: Strategy assessment
      • Table Horizon Pharma: Opportunity assessment
    • Takeda Pharmaceuticals
      • Table Takeda Pharmaceuticals: Key highlights
      • Table Takeda Pharmaceuticals: Strength assessment
      • Table Takeda Pharmaceuticals: Strategy assessment
      • Table Takeda Pharmaceuticals: Opportunity assessment
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report